Biogen
(NASDAQ) BIIB
Biogen Financials at a Glance
Market Cap
$26.26B
Revenue (TTM)
$9.81B
Net Income (TTM)
$1.29B
EPS (TTM)
$8.81
P/E Ratio
20.32
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$178.84
Volume
327,529.124
Open
$179.36
Price
$178.84
Volume
327,529.124
Open
$179.36
Previous Close
$178.96
Daily Range
$177.70 - $180.09
52-Week Range
$114.66 - $202.41
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$178.84
Volume
327,529.124
Open
$179.36
Previous Close
$178.96
Daily Range
$177.70 - $180.09
52-Week Range
$114.66 - $202.41
BIIB News
BIIB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biogen
Industry
Biotechnology
Sector
Health CareEmployees
7,500
CEO
Christopher A. Viehbacher, CPA
Website
www.biogen.comHeadquarters
Cambridge, MA 02142, US
BIIB Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
19%
Net Income Margin
13%
Return on Equity
7%
Return on Capital
7%
Return on Assets
4%
Earnings Yield
4.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$26.26B
Shares Outstanding
146.76M
Volume
327.53K
Short Interest
0.00%
Avg. Volume
1.27M
Financials (TTM)
Gross Profit
$6.91B
Operating Income
$1.88B
EBITDA
$3.10B
Operating Cash Flow
$2.20B
Capital Expenditure
$153.80M
Free Cash Flow
$2.05B
Cash & ST Invst.
$3.82B
Total Debt
$6.95B
Biogen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.28B
-7.1%
Gross Profit
$1.78B
-4.7%
Gross Margin
78.23%
N/A
Market Cap
$26.26B
N/A
Market Cap/Employee
$3.45M
N/A
Employees
7,605
N/A
Net Income
$48.41M
-118.2%
EBITDA
$298.70M
-56.8%
Quarterly Fundamentals
Net Cash
$3.13B
+26.4%
Accounts Receivable
$1.87B
-0.1%
Inventory
$2.17B
-11.9%
Long Term Debt
$6.87B
+40.7%
Short Term Debt
$80.40M
-95.4%
Return on Assets
4.39%
N/A
Return on Invested Capital
7.20%
N/A
Free Cash Flow
$555.90M
-20.0%
Operating Cash Flow
$512.00M
-32.7%